title: Serum and tissue fluid norfloxacin concentrations after oral administration of the drug to healthy dogs.
abstract: Norfloxacin, a 4-quinolone antibiotic, was administered orally to 4 healthy dogs at dosages of 11 and 22 mg/kg of body weight, every 12 hours for 4 days, with a 4-week interval between dosing regimens. Serum and tissue cage fluid (TCF) norfloxacin concentrations were measured at 0, 0.5, 1, 1.5, 2, 3, 4, 5, 6, 8, 10, and 12 hours after the first and seventh dose of each dosing regimen. When administered at a dosage of 11 mg/kg, the mean peak serum concentration (Cmax) was 1.0 microgram/ml at 1 hour, the time of mean peak concentration (Tmax) after the first dose. After the seventh dose, the Cmax was 1.4 micrograms/ml at Tmax of 1.5 hours. The Tmax for the TCF concentration was 5 hours, with Cmax of 0.3 microgram/ml and 0.7 microgram/ml after the first and seventh dose, respectively. When administered at a dosage of 22 mg/kg, the serum Tmax was 2 hours after the first dose, with Cmax of 2.8 micrograms/ml. After the seventh dose, the serum Tmax was 1.5 hours, with Cmax of 2.8 micrograms/ml. The Tmax for the TCF concentration was 5 hours after the first and seventh doses, with Cmax of 1.2 micrograms/ml and 1.6 micrograms/ml, respectively. After the seventh dose, the serum elimination half-life was 6.3 hours for a dosage of 11 mg/kg and was 6.7 hours for a dosage of 22 mg/kg. For serum concentration, the area under the curve from 0 to 12 hours (AUC0----12) was 8.77 micrograms.h/ml and 18.27 micrograms.h/ml for dosages of 11 mg/kg and 22 mg/kg, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: College of Veterinary Medicine, Michigan State University, East Lansing 48823.
authors.forename: R D
authors.initials: RD
authors.lastname: Walker
authors.forename: G E
authors.initials: GE
authors.lastname: Stein
authors.forename: S C
authors.initials: SC
authors.lastname: Budsberg
authors.forename: E J
authors.initials: EJ
authors.lastname: Rosser
authors.forename: K H
authors.initials: KH
authors.lastname: MacDonald
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001826:Body Fluids / Q000378:metabolism; D004285:Dogs / Q000378:metabolism*; D006207:Half-Life; D009643:Norfloxacin / Q000008:administration & dosage / Q000493:pharmacokinetics*
chemical_list: D009643:Norfloxacin